316 related articles for article (PubMed ID: 25938834)
1. [Magnesium isoglycyrrhizinate prevention of chemotherapy-induced liver damage during initial treatment of patients with gastrointestinal tumors].
Yan Y; Mo Y; Zhang D
Zhonghua Gan Zang Bing Za Zhi; 2015 Mar; 23(3):204-8. PubMed ID: 25938834
[TBL] [Abstract][Full Text] [Related]
2. The role of tiopronin for the prevention of chemotherapy-related liver toxicity in advanced colorectal cancer patients treated with mFOLFOX7: a prospective analysis.
Li XP; Wen F; Yang W; Deng YB; Li M; Zhang PF; Tang RL; Li Q; Wei YQ
Tumori; 2014; 100(4):446-51. PubMed ID: 25296595
[TBL] [Abstract][Full Text] [Related]
3. [Protective effect of intraperitoneal transplantation of human liver-derived stem cells at different times against concanavalin A-induced acute liver injury in mice].
Bi YZ; Fan Z; Chen DF; Li SS; Wang QY; Gao PF; Wang QQ; Duan ZP; Chen Y; Kong LB; Wang YB; Hong F
Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):205-210. PubMed ID: 28482408
[No Abstract] [Full Text] [Related]
4. The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen.
Vincenzi B; Santini D; Frezza AM; Berti P; Vespasiani U; Picardi A; Tonini G
Expert Opin Drug Saf; 2011 May; 10(3):345-9. PubMed ID: 21406026
[TBL] [Abstract][Full Text] [Related]
5. [Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases: a randomized, double-blind, multi-doses, active drug controlled, multi-center study].
Mao YM; Zeng MD; Chen Y; Chen CW; Fu QC; Cai X; Wu SM; Chen YG; Sun Y; Li J; Sui YH; Zhao W; Lu LG; Cao AP; Chen HZ
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):847-51. PubMed ID: 19958646
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area].
Qian ZP; Mei X; Zhang YY; Zou Y; Zhang ZG; Zhu H; Guo HY; Liu Y; Ling Y; Zhang XY; Wang JF; Lu HZ
Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):229-233. PubMed ID: 32270660
[No Abstract] [Full Text] [Related]
7. [Effects of Li-Dan-He-Ji on regulating oxidative stress and antagonising infantile cholestatic hepatic fibrosis].
Yi W; Yan S; Tang J; Ma X; Su M; Li H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jul; 35(7):741-745. PubMed ID: 37545453
[TBL] [Abstract][Full Text] [Related]
8. Some biochemical and haematological changes in rats pretreated with aqueous stem bark extract of Lophira lanceolata and intoxicated with paracetamol (acetaminophen).
Aba PE; Ozioko IE; Udem ND; Udem SC
J Complement Integr Med; 2014 Dec; 11(4):273-7. PubMed ID: 25263311
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of different doses of magnesium isoglycyrrhizinate in the treatment of chronic liver disease with elevated ALT: a meta-analysis].
Hu PP; Zhu CL
Zhonghua Gan Zang Bing Za Zhi; 2023 Aug; 31(8):835-841. PubMed ID: 37723065
[No Abstract] [Full Text] [Related]
10. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
[No Abstract] [Full Text] [Related]
11. Magnesium isoglycyrrhizinate inhibits inflammatory response through STAT3 pathway to protect remnant liver function.
Tang GH; Yang HY; Zhang JC; Ren JJ; Sang XT; Lu X; Zhong SX; Mao YL
World J Gastroenterol; 2015 Nov; 21(43):12370-80. PubMed ID: 26604644
[TBL] [Abstract][Full Text] [Related]
12. Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer.
Ducreux M; Bennouna J; Hebbar M; Ychou M; Lledo G; Conroy T; Adenis A; Faroux R; Rebischung C; Bergougnoux L; Kockler L; Douillard JY;
Int J Cancer; 2011 Feb; 128(3):682-90. PubMed ID: 20473862
[TBL] [Abstract][Full Text] [Related]
13. [Study on the damage of liver in patients with SARS].
Guan YJ; Tang XP; Yin CB; Yi ZQ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 May; 16(5):267-70. PubMed ID: 15132787
[TBL] [Abstract][Full Text] [Related]
14. Comparison between hypersensitivity reactions to cycles of modified FOLFOX6 and XELOX therapies in patients with colorectal cancer.
Ohta H; Hayashi T; Murai S; Shiouchi H; Ando Y; Kumazawa S; Ito K; Ikeda Y; Matsuoka H; Maeda K; Kawada K; Yasuda K; Yamada S
Cancer Chemother Pharmacol; 2017 May; 79(5):1021-1029. PubMed ID: 28391355
[TBL] [Abstract][Full Text] [Related]
15. [FOLFOX4 regimen versus DP(O)F regimen for advanced gastric cancer].
Wu F; Zhang HG; Ran FW; Zhang XR; Shi YK
Ai Zheng; 2008 Apr; 27(4):413-7. PubMed ID: 18423129
[TBL] [Abstract][Full Text] [Related]
16. [Dynamic change study of dermatitis medicamentosa-like of trichloroethylene patients with liver damage].
Liu W; Zhang YF; Zhang ZM; Li PM; Jiang XD; Zhou GF; Liu JJ
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2011 Oct; 29(10):790-3. PubMed ID: 22468317
[TBL] [Abstract][Full Text] [Related]
17. [Role of neutrophils in treatment of rats with D-galactosamine-induced acute liver failure with bone marrow mesenchymal stem cells].
Zhao X; Shi XL; Zhang ZH; Ma HC; Yuan XW; Ding YT
Zhonghua Gan Zang Bing Za Zhi; 2016 Aug; 24(8):601-607. PubMed ID: 27788708
[No Abstract] [Full Text] [Related]
18. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
[TBL] [Abstract][Full Text] [Related]
19. Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin.
Petrioli R; Pascucci A; Francini E; Marsili S; Sciandivasci A; Tassi R; Civitelli S; Tanzini G; Lorenzi M; Francini G
Cancer Chemother Pharmacol; 2008 Jan; 61(1):105-11. PubMed ID: 17429632
[TBL] [Abstract][Full Text] [Related]
20. Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.
Schmoll HJ; Tabernero J; Maroun J; de Braud F; Price T; Van Cutsem E; Hill M; Hoersch S; Rittweger K; Haller DG
J Clin Oncol; 2015 Nov; 33(32):3733-40. PubMed ID: 26324362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
